CV Sciences Inc (CVSI OTCQB) stock market data APIs
$0.0298
0(0%)
as of May 15, 2026
Try our APIs with
free plan!
CV Sciences Inc Financial Data Overview
Price chart is built with
Anychart
CV Sciences, Inc. engages in the development, manufacture, marketing, and sale of herbal supplements, hemp-based cannabidiol (CBD), and plant-based food products in North America. It offers its products under the PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
Prev. Close
0.0298
Open
0.0298
High
0.0298
Low
0.0298
52 wk Range
0.02-0.1
Market Cap
5 707 K
Shares Outstanding
193 M
Revenue
13 789 K
EPS
-0.0011
Beta
0.448
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CV Sciences Inc data using free add-ons & libraries
Get CV Sciences Inc Fundamental Data
CV Sciences Inc Fundamental data includes:
- Net Revenue: 13 789 K
- EBITDA: -278 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-26
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CV Sciences Inc News
New
CV Sciences outlines non-cannabinoid product launches and margin gains as company targets cash flow breakeven through 2026
Earnings Call Insights: CV Sciences (CVSI) Q4 2025 MANAGEMENT VIEW * Joseph Dowling, CEO, highlighted that "throughout 2025, we made meaningful progress against our top priorities, improving margi...
Promising Penny Stocks To Consider In February 2026
As February 2026 kicks off, major stock indexes in the United States have shown impressive gains, with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing a record high. In...
3 Promising Penny Stocks With Market Caps Over $10M
As of December 2025, major U.S. stock indexes have been experiencing a downturn, with the S&P 500 and Dow Jones Industrial Average marking their fourth consecutive loss amid concerns over an AI bubble...
Trump expected to sign EO to reclassify marijuana as soon as Monday, CNBC says
Cannabis stocks jumped on Friday following reports that President Donald Trump will significantly ease federal restrictions on marijuana, with an executive order seen as coming as soon as Monday, CNBC...
Get CV Sciences Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
